Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|June 9, 2020
An Electrochemiluminescence-Based Assay for MeCP2 Protein VariantsHannes Steinkellner, Alexander V Beribisky, Philip Mausberg, et al.
HLA|October 21, 2025
LMP2A-Targeting CAR-T Cells Equipped With Inducible IL-18 to Address EBV-Associated MalignanciesAnna Christina Dragon, Stefanie Thoelke, Philip Mausberg, et al.
Frontiers in Immunology|April 10, 2023
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximabSabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.
Frontiers in Medicine|December 13, 2021
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?Daniel Gussarow, Agnes Bonifacius, Anne Cossmann, et al.
Molecular Therapy. Oncology|July 13, 2026
Next-generation LMP2A-targeting TCR-recombinant T cells with inducible IL-18 expression to treat EBV-associated malignanciesAgnes Bonifacius, Philip Mausberg, Friederike Floegel, et al.
Plos Pathogens|September 26, 2024
DNA methylation profiling identifies TBKBP1 as potent amplifier of cytotoxic activity in CMV-specific human CD8+ T cellsZheng Yu, Varun Sasidharan-Nair, Thalea Buchta, et al.
Frontiers in Bioengineering and Biotechnology|April 28, 2022
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell TherapyAgnes Bonifacius, Sabine Tischer-Zimmermann, Maria Michela Santamorena, et al.
Pageof 1